GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DRI Healthcare Trust (FRA:3IJ0) » Definitions » EV-to-Revenue

DRI Healthcare Trust (FRA:3IJ0) EV-to-Revenue : 3.68 (As of Dec. 14, 2024)


View and export this data going back to 2022. Start your Free Trial

What is DRI Healthcare Trust EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, DRI Healthcare Trust's enterprise value is €593.7 Mil. DRI Healthcare Trust's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 was €161.4 Mil. Therefore, DRI Healthcare Trust's EV-to-Revenue for today is 3.68.

The historical rank and industry rank for DRI Healthcare Trust's EV-to-Revenue or its related term are showing as below:

FRA:3IJ0' s EV-to-Revenue Range Over the Past 10 Years
Min: 2.3   Med: 4.97   Max: 8.24
Current: 3.56

During the past 3 years, the highest EV-to-Revenue of DRI Healthcare Trust was 8.24. The lowest was 2.30. And the median was 4.97.

FRA:3IJ0's EV-to-Revenue is ranked worse than
62.88% of 994 companies
in the Drug Manufacturers industry
Industry Median: 2.495 vs FRA:3IJ0: 3.56

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-12-14), DRI Healthcare Trust's stock price is €7.95. DRI Healthcare Trust's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 was €2.86. Therefore, DRI Healthcare Trust's PS Ratio for today is 2.78.


DRI Healthcare Trust EV-to-Revenue Historical Data

The historical data trend for DRI Healthcare Trust's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DRI Healthcare Trust EV-to-Revenue Chart

DRI Healthcare Trust Annual Data
Trend Dec21 Dec22 Dec23
EV-to-Revenue
2.52 5.30 5.26

DRI Healthcare Trust Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.29 5.26 5.70 4.80 3.91

Competitive Comparison of DRI Healthcare Trust's EV-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, DRI Healthcare Trust's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DRI Healthcare Trust's EV-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, DRI Healthcare Trust's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where DRI Healthcare Trust's EV-to-Revenue falls into.



DRI Healthcare Trust EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

DRI Healthcare Trust's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=593.694/161.378
=3.68

DRI Healthcare Trust's current Enterprise Value is €593.7 Mil.
DRI Healthcare Trust's Revenue for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €161.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DRI Healthcare Trust  (FRA:3IJ0) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

DRI Healthcare Trust's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=7.95/2.861
=2.78

DRI Healthcare Trust's share price for today is €7.95.
DRI Healthcare Trust's Revenue per Share for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.86.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DRI Healthcare Trust EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of DRI Healthcare Trust's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


DRI Healthcare Trust Business Description

Traded in Other Exchanges
Address
100 King Street West, 1 First Canadian Place, Suite 7250, Toronto, ON, CAN, M5X 1B1
DRI Healthcare Trust is engaged in pharmaceutical royalty monetization by providing capital to inventors, academic institutions, and biopharma companies. Trust was formed to provide Unitholders with differential exposure to the pharmaceutical and biotechnology industries through ownership and acquisitions of pharmaceutical royalties. In return for providing capital to biopharmaceutical innovators, the company is building a diversified portfolio of interests in medicines that have a demonstrable positive impact on the world. The Trust has concluded that it operates as one segment, primarily focused on acquiring royalty assets. Geographically the trust generates major revenue from the United States. The trust also generates Income from markets such as Japan, and the European Union.

DRI Healthcare Trust Headlines

No Headlines